<unk>  is part of a group of disorders that affect the endocrine system through development of neoplastic lesions in the thyroid, the parathyroid gland, and the adrenal gland.<unk>  was first described by Dr. John H. Sipple, an American physician, in 1961 by reporting a case of a patient with pheochromocytoma, medullary thyroid carcinoma and parathyroid adenoma. Development of<unk>  is the result of genetic mutations. RET gene is involved in the pathogenesis of<unk> .<unk> A is associated with medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.<unk> B is associated with medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus, and mucosal and digestive neurofibromatosis. Surgery is the mainstay of treatment for<unk> .
Multiple endocrine neoplasia type 2
Multiple endocrine neoplasia type 1
Addison-Gull syndrome
McCune-Albright syndrome
Addison-gull syndrome
Multiple endocrine neoplasia type 1 pathophysiology
Albright like syndrome
Alstrom syndrome